Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 4, 2022
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
[ Mon, Apr 04th 2022
] - WOPRAI
Sun, April 3, 2022
Fri, April 1, 2022
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
Michael Turrin Downgraded (BLND) to Hold and Held Target at $5 on, Apr 1st, 2022
Michael Turrin of Wells Fargo, Downgraded "Blend Labs, Inc." (BLND) to Hold and Held Target at $5 on, Apr 1st, 2022.
Michael has made no other calls on BLND in the last 4 months.
There are 2 other peers that have a rating on BLND. Out of the 2 peers that are also analyzing BLND, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ryan Tomasello of "Keefe, Bruyette & Woods" Initiated at Hold and Held Target at $12 on, Monday, February 14th, 2022
This is the rating of the analyst that currently disagrees with Michael
- Michael Ng of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $9 on, Thursday, March 31st, 2022
